Pantoprazole and rabeprazole are two medications that belong to a class of drugs known as proton pump inhibitors (PPIs). These medications are primarily used to treat various gastrointestinal disorders, including gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome. By inhibiting the proton pump in the stomach lining, both pantoprazole and rabeprazole effectively reduce the production of stomach acid, providing relief from symptoms associated with excess acidity. While both medications serve similar purposes and are often prescribed for comparable conditions, they differ in their chemical composition, pharmacokinetics, and potential side effects. Understanding these differences can help patients and healthcare providers make informed decisions about which medication might be more suitable…